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Abstract: Background
Extended-spectrum cephalosporin resistance (ESC-R) in Escherichia coli and
Klebsiella pneumoniae is a healthcare threat; high gastrointestinal carriage rates are
reported from South-east Asia. Colonisation prevalence data in Cambodia are lacking.
The aim of this study was to determine gastrointestinal colonisation prevalence of
ESC-resistant E. coli (ESC-R-EC) and K. pneumoniae (ESC-R-KP) in Cambodian
children/adolescents and associated socio-demographic risk factors; and to
characterise relevant resistance genes, their genetic contexts, and the genetic
relatedness of ESC-R strains using whole genome sequencing (WGS).
Results
Faeces and questionnaire data were obtained from individuals <16 years in north-
western Cambodia, 2012. WGS of cultured ESC-R-EC/KP was performed (Illumina).
Maximum likelihood phylogenies were used to characterise relatedness of isolates;
ESC-R-associated resistance genes and their genetic contexts were identified from de
novo assemblies using BLASTn and automated/manual annotation. 82/148 (55%) of
children/adolescents were ESC-R-EC/KP colonised; 12/148 (8%) were co-colonised
with both species. Independent risk factors for colonisation were hospitalisation (OR:
3.12, 95%, CI [1.52-6.38]) and intestinal parasites (OR: 3.11 [1.29-7.51]); school
attendance conferred decreased risk (OR: 0.44 [0.21-0.92]. ESC-R strains were
diverse; the commonest ESC-R mechanisms were blaCTX-M 1 and 9 sub-family
variants. Structures flanking these genes were highly variable, and for blaCTX-M-15, -
55 and -27, frequently involved IS26. Chromosomal blaCTX-M integration was
common in E. coli.
Conclusions
Gastrointestinal ESC-R-EC/KP colonisation is widespread in Cambodian
children/adolescents; hospital admission and intestinal parasites are independent risk
factors. The genetic contexts of blaCTX-M are highly mosaic, consistent with rapid
horizontal exchange. Chromosomal integration of blaCTX-M may result in stable
propagation in these community-associated pathogens.
Corresponding Author: Jon van Aartsen
University of Liverpool
UNITED KINGDOM
Corresponding Author Secondary
Information:
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Corresponding Author's Institution: University of Liverpool
Corresponding Author's Secondary
Institution:
First Author: J J van Aartsen
First Author Secondary Information:
Order of Authors: J J van Aartsen
C E Moore
C M Parry
P Turner
N Phot
S Mao
K Suy
T Davies
A Giess
A E Sheppard
T EA Peto
N PJ Day
D W Crook
A S Walker
N Stoesser
Order of Authors Secondary Information:
Response to Reviewers: 28th February, 2019
Dear Dr Devoto,
RE: Epidemiology of paediatric gastrointestinal colonisation by extended spectrum
cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-
west Cambodia. Revised manuscript BMC Microbiology (MCRO-D-17-00672)
Thank you for informing us that our article is potentially acceptable for publication,
pending essential editorial revisions. We have carefully addressed the editorial
revisions as follows:
_____________________________________________________________________________
___
1. & 2.Funding / competing interests sections amended. Please note, there are no
financial competing interests.
3.As requested, methods section has been moved to after Conclusions
4.Details of consent process now included in the Methods under "Patients and setting”.
In the “ethical approval and consent to participate” section it is now clearly states that
all included participants gave informed consent and that samples were excluded from
the study if this had not been obtained.
5.Done.
6.Individual contributions of all authors to the manuscript have now been specified.
7.We have uploaded the data to NCBI BioProject (PRJNA391054), and referenced this
in our manuscript.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
8.Done.
9.Done.
_____________________________________________________________________________
___
We hope that you find our revisions satisfactory and that the manuscript is now
acceptable for publication in BMC Microbiology.
Yours sincerely,
Jon van Aartsen
MBChB, BSc, PhD, MRCP
Phone + 447955541677
jjvanaartsen@outlook.com
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Epidemiology of paediatric gastrointestinal colonisation by extended spectrum 1 
cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-2 
west Cambodia 3 
 4 
JJ van Aartsen1,2#, CE Moore1, CM Parry3, P Turner4,5, N Phot6, S Mao6, K Suy6, T 5 
Davies1, A Giess1, AE Sheppard1, TEA Peto1, NPJ Day5,7, DW Crook1, AS Walker1, N 6 
Stoesser1 7 
 8 
1 Nufﬁeld Department of Clinical Medicine and the National Institute for Health Research 9 
Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, United 10 
Kingdom. 11 
2 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and 12 
Global Health, University of Liverpool, Liverpool, United Kingdom. 13 
3 Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK 14 
4 Cambodia-Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, 15 
Cambodia. 16 
5 Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, 17 
University of Oxford, Oxford, UK 18 
6 Angkor Hospital for Children, Siem Reap, Cambodia. 19 
7 Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol 20 
University, Bangkok, Thailand. 21 
Keywords: Paediatric, ESBL, carriage, Cambodia 22 
 23 
Manuscript Click here to
access/download;Manuscript;bmcmicro_camb_esbl_17022019
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
#Corresponding author:  24 
Dr Jon J. van Aartsen, Department of Clinical Infection, Microbiology and Immunology, 25 
Institute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 26 
8 West Derby Street, Liverpool, L69 7BE, United Kingdom. E-mail: 27 
jjvanaartsen@outlook.com 28 
 29 
Alternative corresponding author: 30 
Dr Nicole Stoesser, Department of Microbiology/Infectious Diseases, John Radcliffe 31 
Hospital, Headley Way, Headington, OX3 9DU, United Kingdom. Tel: +44-(0)1865 220856; 32 
E-mail: nicole.stoesser@ndm.ox.ac.uk 33 
 34 
ABSTRACT  35 
Background 36 
Extended-spectrum cephalosporin resistance (ESC-R) in Escherichia coli and Klebsiella 37 
pneumoniae is a healthcare threat; high gastrointestinal carriage rates are reported from 38 
South-east Asia. Colonisation prevalence data in Cambodia are lacking. The aim of this study 39 
was to determine gastrointestinal colonisation prevalence of ESC-resistant E. coli (ESC-R-40 
EC) and K. pneumoniae (ESC-R-KP) in Cambodian children/adolescents and associated 41 
socio-demographic risk factors; and to characterise relevant resistance genes, their genetic 42 
contexts, and the genetic relatedness of ESC-R strains using whole genome sequencing 43 
(WGS).   44 
Results 45 
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Faeces and questionnaire data were obtained from individuals <16 years in north-western 46 
Cambodia, 2012. WGS of cultured ESC-R-EC/KP was performed (Illumina). Maximum 47 
likelihood phylogenies were used to characterise relatedness of isolates; ESC-R-associated 48 
resistance genes and their genetic contexts were identified from de novo assemblies using 49 
BLASTn and automated/manual annotation. 82/148 (55%) of children/adolescents were ESC-50 
R-EC/KP colonised; 12/148 (8%) were co-colonised with both species. Independent risk 51 
factors for colonisation were hospitalisation (OR: 3.12, 95%, CI [1.52-6.38]) and intestinal 52 
parasites (OR: 3.11 [1.29-7.51]); school attendance conferred decreased risk (OR: 0.44 [0.21-53 
0.92]. ESC-R strains were diverse; the commonest ESC-R mechanisms were blaCTX-M 1 and 9 54 
sub-family variants. Structures flanking these genes were highly variable, and for blaCTX-M-15, 55 
-55 and -27, frequently involved IS26. Chromosomal blaCTX-M integration was common in E. coli.   56 
Conclusions 57 
Gastrointestinal ESC-R-EC/KP colonisation is widespread in Cambodian 58 
children/adolescents; hospital admission and intestinal parasites are independent risk factors. 59 
The genetic contexts of blaCTX-M are highly mosaic, consistent with rapid horizontal 60 
exchange. Chromosomal integration of blaCTX-M may result in stable propagation in these 61 
community-associated pathogens. 62 
 63 
MAIN TEXT 64 
BACKGROUND 65 
Escherichia coli and Klebsiella pneumoniae are two bacterial pathogens of the 66 
Enterobacteriaceae family that can cause a wide spectrum of clinical disease, ranging from 67 
cystitis and intra-abdominal abscesses to sepsis. Both species also asymptomatically colonise 68 
the gastrointestinal tract, a reservoir that assists in the acquisition and spread of antimicrobial 69 
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resistance (AMR)[1, 2]. The increasing prevalence of AMR worldwide is reducing the efficacy 70 
of our limited armamentarium of empirical broad-spectrum antibiotics, such as extended-71 
spectrum cephalosporins (ESCs), resulting in increased healthcare costs and mortality[3-5].  72 
 73 
Recent reports from South-east Asia show substantial variation between country and cohort in 74 
gastrointestinal colonisation by Enterobacteriaceae possessing Ambler class A extended 75 
spectrum beta-lactamases (ESBLs) and/or class C AmpC enzymes, which can hydrolyse third 76 
and fourth generation cephalosporins. In the Lao People’s Democratic Republic, for example, 77 
23% of pre-school children carried these strains, in contrast to a much higher prevalence of 78 
65.7% in a rural Thai adult population[6-8]. Data describing the prevalence and mechanisms 79 
of antibiotic resistance in Cambodia are limited to only a few studies. Vlieghe and colleagues 80 
found 49.7% of Enterobacteriaceae from blood cultures in Phnom Penh from 2007-2010 were 81 
cefotaxime-resistant, mostly due to CTX-M-15 and CTX-M-14 enzymes[9]. Studies from 82 
2004/5 and 2007-2011 identified ESC resistance in 36-44% of urinary tract infection 83 
isolates[10, 11]. Recent data from a Cambodian reference laboratory suggests that the 84 
prevalence of ESBL resistance amongst Enterobacteriaceae isolated from hospitalised and 85 
community-based patients increased from 23.8% in 2012 to 38.4% in 2015[12]. The 86 
gastrointestinal colonisation prevalence of ESC-resistant (ESC-R) E. coli and K. pneumoniae 87 
in Cambodia has previously only been investigated in hospitalised neonates[13], where on 88 
initial admission 21% were colonised with ESC-R E. coli (ESC-R-EC) and 33% with ESC-R 89 
K. pneumoniae (ESC-R-KP), increasing to 34% and 42% respectively on repeat admissions. 90 
Our study aimed to expand on this work by: (i) estimating the prevalence of gastrointestinal 91 
colonisation with ESC-R-EC and ESC-R-KP in Cambodian children and adolescents, and the 92 
molecular mechanisms responsible; (ii) investigating socio-demographic risk factors for ESC-93 
R colonisation; (iii) determining genetic relatedness of ESC-R strains.    94 
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RESULTS 95 
Sampling, culture and basic demographics 96 
In total, 196 faecal samples were obtained from a consecutive subset of children/adolescents 97 
enrolled in an intestinal parasite prevalence study. 48 samples were excluded from this study 98 
because of: (i) lack of specific consent for wider use of the faecal samples beyond the faecal 99 
parasite survey (n=36); (ii) no epidemiological data records (n=1); (iii) no (n=3) or poor 100 
(n=5) growth on culture; or (iv) replicate samples for the same patient (n=3), leaving 148 101 
samples/individuals for analysis.   102 
 103 
Overall, 184 distinct colony types grew within the cefpodoxime inhibition zones; 141 were 104 
pink (presumed E. coli) and 43 were blue (presumed Klebsiella spp., Enterobacter spp. or 105 
Citrobacter spp.). All pink colonies but only 22/43 (54%) blue colonies were confirmed as 106 
phenotypically ESC-R using BSAC methods. All 163 confirmed ESC-R isolates were 107 
sequenced; two failed and were excluded from further analysis. Of the 161 sequences, in 108 
silico species identification confirmed 135 (84%) isolates were E. coli, 18 (11%) 109 
K. pneumoniae, and 8 (5%) Enterobacter spp. 38 E. coli isolates and one K. pneumoniae 110 
isolate were genetically sufficiently closely related to another isolate obtained from the same 111 
patient sample to be considered as the same strain (defined as ≤5 chromosomal SNVs); these 112 
were also excluded leaving 122 isolates for analysis. None of the 148 faecal samples yielded 113 
imipenem resistant colonies. 114 
 115 
Participants were median 4.2 years old (interquartile range: 1.1-8.8) at sample collection; 116 
70/148 (47%) were male. 70/147 (48%; 1 missing) were inpatients at sample collection. 117 
Although most were from Siem Reap province (99/148 [67%]), the hospital catchment is 118 
such that the remainder were recruited from 10 other provinces. 16/148 (11%) were clinically 119 
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malnourished, and 23/148 (16%) had ≥1 underlying chronic medical condition including HIV 120 
(n=5), haematological disease (n=3), congenital cardiac disease (n=5), tuberculosis (n=4), 121 
and asthma (n=2)(Table 1). 122 
 123 
Prevalence of and risk factors for colonisation with ESC-R EC and/or ESC-R-KP 124 
A total of 114 confirmed ESC-R-EC (n=97) and ESC-R-KP (n=17) remained in the analysis 125 
and were carried by 82/148 participants, giving a combined ESC-R-EC/KP prevalence of 126 
55% (95% CI: 47%-64%); 53% for ESC-R EC (79/148 patients; 95% CI: 45%-62%) and 127 
10% for ESC-R KP (15/148 patients; 95% CI: 6%-16%). Co-colonisation with both ESC-R-128 
EC and ESC-R-KP was observed in 12/82 (15%). Independent risk factors for ESC-R-EC/KP 129 
colonisation included being a current inpatient (OR=3.64; 95% CI [1.71-7.74), p=0.001) and 130 
the presence of faecal parasites (OR=3.96 [1.55-10.12], p=0.004). ESC-R-EC/KP 131 
colonisation was lower in males (OR=0.39 [0.18-0.84], p=0.015) and in those attending 132 
school (OR=0.39 [0.18-0.83], p=0.015)(Table 1). 133 
 134 
Sequence type, Ambler class and genetic mechanisms of ESC-R  135 
The 97 ESC-R-EC isolates came from 33 known and 6 novel STs (Fig.1, for details see Table 136 
S1). 22% (17/79) of patients were colonised by at least two different ESC-R-EC STs, 137 
although this may underestimate diversity as only a small number of colonies (≤3) were 138 
sampled per patient [14]. The 17 ESC-R-KP strains came from 11 known and 3 novel STs 139 
(n=4 isolates) (Fig.2, Table S2). Two patients were colonised by two different ESC-R 140 
K. pneumoniae STs (2/15, 13%).  141 
 142 
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In total, 77% (88/114) and 23% (26/114) of isolates displayed Ambler class A or C 143 
phenotypes, respectively (Table 2). Neither species were associated with Ambler class A 144 
(76% [74/97] versus 82% [14/17]) or class C (24% [23/97] versus 18% [3/17]; Fishers exact 145 
test; p=0.759). In all class A isolates the phenotype could be explained by the presence of one 146 
(84/88, 95%) or two (4/88, 5%) blaCTX-M  genes; blaSHV (12/88, 14%) and blaVEB (1/88, 1%) 147 
occurred less commonly. Class C gene families were only identified in 38% (10/26) of 148 
phenotypically class C isolates: specifically blaCMY-2 (8/26, 31%) or blaDHA (2/26, 8%). In the 149 
remaining 16 isolates, the genetic basis for the class C phenotype was unclear; of note, 150 
however, ampC promoter mutations were not assessed.  151 
 152 
111 blaCTX-M genes were found in 94% (107/114) of ESC-R-EC/KP, with two separate alleles 153 
identified in 4% of isolates (4/114). The most frequently identified allele was blaCTX-M-15 154 
(53/111, 48%), followed by: blaCTX-M-55 (24/111, 22%), blaCTX-M-14 (17/111,15%), blaCTX-M-27 155 
(14/111, 13%) and blaCTX-M-24 (3/111, 3%). Two different blaCTX-M alleles were found in 21% 156 
(18/82) of individuals carrying ESC-R-EC/KP. 157 
 158 
All 15 identified blaSHV genes were found only in ESC-R-KP. Of these, 3/15 (20%) are likely 159 
to confer ESC-R: blaSHV-27-like (1/15, 7%), 1/15 blaSHV-28 (1/15, 7%),  blaSHV-99-like (1/15, 7%); 160 
the remaining possess either narrow-spectrum beta-lactamase activity (11/15, 73%: 3/15 161 
blaSHV-1/ SHV-1-like, 20%; 4/15 blaSHV-11/ SHV-11-like, 27%; 3/15 blaSHV-33, 20.0%; and 1/15 162 
blaSHV-83, 7%) or their beta-lactamase phenotype is unknown (1/15, 7%: 1/15 blaSHV-142 , 7%). 163 
All blaSHV-positive ESC-R-KP possessed other genes that could explain their ESC-R 164 
phenotype: blaCTX-M-14 (2/15, 13%), blaCTX-M-15 (10/15, 67%), blaCTX-M-27 (2/15, 13%), or 165 
blaDHA  (1/15, 7%). The study population carriage prevalence of common ESC-R conferring 166 
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genetic mechanisms encoded by ESC-R-EC/KP was therefore: 53% blaCTX-M (78/148), 2% 167 
blaSHV (3/148), 1% blaVEB (1/148), 5% blaCMY-2 (8/148), 1% blaDHA (2/148). Two individuals 168 
(1%) carried isolates with blaOXA-48 (one K. pneumoniae ST48 [56B1] and one E. coli ST648 169 
[94P1]); no other carbapenem resistance mechanisms were identified. Both isolates were 170 
resistant to ertapenem with a minimum inhibitory concentration (MIC) of >1µg/ml); 56B1 171 
had intermediate resistance to imipenem (MIC 4µg/ml) and meropenem (MIC 8µg/ml), 172 
whilst 94P1 was sensitive to both with MICs of 1µg/ml and 0.25µg/ml, respectively. 173 
 174 
Genetic context of blaCTX-M  175 
For the 41 E. coli harbouring blaCTX-M-15, it was chromosomally located in five cases (12%), 176 
and likely in plasmid contexts in two; in the remaining cases it was not possible to determine 177 
wider chromosomal/plasmid location (Table 3). One isolate (38P1) harboured short contigs 178 
containing truncated blaCTX-M-15, leaving 40 cases in which to evaluate the immediate 179 
flanking contexts surrounding the blaCTX-M gene. All contained ISEcp1 upstream of blaCTX-M-180 
15, but with considerable evidence of additional mobilisation events/mosaicism (Table 3). In 181 
particular, ISEcp1 was truncated by IS26 at 24, 497, 524, 1067, 1173, 1421, or 1489bp in 13 182 
isolates, consistent with at least seven IS26-associated insertion events within ISEcp1(Fig.3). 183 
Another 13 ISEcp1 elements were truncated by contig breaks, without any specific associated 184 
genetic signatures, although contig breaks are frequently due to repeat structures and may 185 
therefore have represented additional disruption events. One isolate had an intact ISEcp1 186 
element, without any wider flanking upstream context. The 13 cases with an intact ISEcp1 187 
were consistently flanked by variable lengths of Tn2, which was truncated by an IS26 right 188 
IRR in 2/7 evaluable cases (and by an unknown sequence in the other 5/7). Two isolates had 189 
a complete Tn2 structure interrupted by ISEcp1-blaCTX-M-15 (TCTCA-TCTCA and TTTTA-190 
TAAAA target site sequences [TSSs] respectively)(Fig.3). Overall, genetic contexts of 191 
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blaCTX-M-15 were consistent with integration and mobilisation of ISEcp1-blaCTX-M-15 within a 192 
Tn2 element, as previously described(26), with subsequent rearrangement events facilitated 193 
by IS26 and perhaps other ISs(27)(Table S3).   194 
 195 
For the 24 E. coli harbouring blaCTX-M-55, it was chromosomally located in 4 (17%), plasmid 196 
in 4 (17%) and unknown in 16 (67%). One contig contained a truncated blaCTX-M-55, leaving 197 
23 evaluable contexts. Similar to blaCTX-M-15, it was invariably associated with ISEcp1 198 
upstream of blaCTX-M-55 (Fig.4), which was often incomplete, representing at least 3 different 199 
IS26-associated ISEcp1 disruption events (Table 3). Intact ISEcp1 were flanked by variable 200 
lengths of Tn2 sequence, apart from 120P1 where the contig was truncated immediately at 201 
the 5’ end of ISEcp1. One isolate (2P1) had the same blaCTX-M/Tn2 unit as for blaCTX-M-15 (but 202 
with TACTC-TAAAA), consistent with the evolution of blaCTX-M-55 from blaCTX-M-15 (1 SNV 203 
difference) within this unit (Figs.3, 4). 204 
 205 
For the 15 E. coli harbouring blaCTX-M-14, it was chromosomally located in 2 (13%) cases, 206 
plasmid-associated in 5 (33%), and unknown in 8 (53%). Again, it was invariably associated 207 
with ISEcp1, but more often complete and with different mechanisms of disruption (2 208 
ISVsa5-like sequence, one IS1S R IRR). All cases had an IS903 element at the 3’ end of 209 
blaCTX-M-14; this had been disrupted in 6 cases, with additional contig breaks in 5 cases 210 
(Fig.5). Two of three E. coli blaCTX-M-24 contexts were chromosomal, with flanking contexts 211 
similar to blaCTX-M-14 (Fig.S1). In the 12 blaCTX-M-27 cases, the ISEcp1 element had been 212 
disrupted by an IS26 L IRR in all contexts, at 149, 192, 208 and 388bp, but the wider genetic 213 
context of this structure was indeterminable in all cases (Fig.S2). 214 
 215 
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Overall, blaCTX-M was chromosomal in 13/92 cases (14%; 13/25 [52%] cases where plasmid 216 
versus chromosomal location could be assessed), suggesting that CTX-M genes may be 217 
incorporated chromosomally and indiscriminately in significant numbers of colonising E. 218 
coli, with possible implications for their stable propagation within the wider E. coli 219 
population. 220 
 221 
For K. pneumoniae, 12 isolates harboured blaCTX-M-15, in a plasmid-associated context in 9/12 222 
cases, and an unknown context in 3/12 cases. Three isolates harboured a complete blaCTX-M-223 
15/Tn2 complex with GTTAA-GTTAA TSS, most consistent with a direct transposition of 224 
this element into a plasmid context. In the other isolates, the ISEcp1-blaCTX-M-15-ORF477 was 225 
flanked by variable stretches of Tn2-associated sequence identical to that found in the E. coli 226 
isolates, and similarly truncated either as a result of contig breaks, or by IS26 inverted 227 
repeats, consistent with between species and within species mobilisation (Fig.S3).  228 
 229 
Four K. pneumoniae isolates harboured blaCTX-M-9 group genes; two of these (blaCTX-M-14) 230 
shared the same ISEcp1 (Fig.5) and ~18kb upstream flanking plasmid sequence; and two 231 
(blaCTX-M-27) an ISEcp1 element truncated at position 1499 by an IS26 L IRR (Fig.S2).  232 
 233 
DISCUSSION 234 
We observed significant gastrointestinal carriage prevalence of both ESC-R-EC and ESC-R-235 
KP in Cambodian children sampled in 2012; approximately one in twelve children was co-236 
colonised with ESC-R strains of both species. A wide diversity of ESC-R strain types was 237 
observed, including several genotypes categorised as “high risk” clones, such as E. coli STs 238 
38, 405, 131, 354 and 648[15]. The predominant ESC-R genotypic mechanism was blaCTX-M, 239 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
with the major allelic variants being those widely described elsewhere in Asia (Group 1: 240 
blaCTX-M-15, -55, Group 9: blaCTX-M-14, -24, -27). Approximately one-third of the Cambodian 241 
population is <18 years old, so this group may be acting as a significant reservoir for the 242 
spread of antimicrobial resistant organisms.  243 
 244 
We did not identify any carbapenem-resistant isolates using our imipenem-based screening 245 
method; however, two (1%) individuals were colonised with transmissible carbapenemase 246 
genes identified on sequencing of cultured isolates. These isolates were phenotypically 247 
susceptible or intermediately-susceptible to imipenem, which has since been shown to be a 248 
less sensitive indicator of carbapenemase - particularly blaOXA-48 - presence, and we may 249 
therefore have been underestimating the prevalence of these genes [16]. Nevertheless, our 250 
results are consistent with other Cambodian datasets, including an earlier study (2007-2010) 251 
where no carbapenemase genes were identified in 183 Enterobacteriaceae blood culture 252 
isolates by means of PCR and a more recent study (2013-2014) where only 2 of 289 (0.7%) 253 
hospitalised neonates were found to harbour imipenem-resistant isolates [9, 13]. This could 254 
be explained by a much lower antibiotic selection pressure resulting from poor local 255 
availability of carbapenems compared with other neighbouring countries such as Thailand at 256 
the time of the study. Of note, the blaOXA-48-E. coli isolate from this study was isolated from 257 
an outpatient without any known chronic health problems, suggesting there may be some 258 
carriage of carbapenem-resistant isolates in the community (or that we missed a healthcare 259 
exposure for this individual). Repeat assessment of the extent of carbapenem-resistant EC/KP 260 
in both community and hospitalised individuals in Cambodia is warranted. 261 
 262 
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Independent risk factors for colonisation by ESC-R-EC/KP included inpatient status, 263 
consistent with transmission within hospital, and/or selection of these organisms from low-264 
level carriage by the use of antibiotics on admission given the high burden of infectious 265 
diseases in this region. Infection control in resource-limited settings remains challenging, and 266 
despite improvements within the study hospital[17], recent longitudinal surveillance within 267 
the neonatal care unit identified high rates of import of ESC-R-KP (62% colonised on 268 
admission) as well as nosocomial acquisition (23%)[13]. Inpatient acquisition of ESC-R-269 
EC/KP has also been identified as a major problem in other low/middle-income settings[18]. 270 
The specific effect of faecal parasites on gut microbiota is not well-studied, but they are 271 
thought to significantly perturb microbial diversity[19]. Parasite infestation may also result in 272 
inappropriate antimicrobial use, including antibiotics, perhaps leading to secondary 273 
colonization with drug-resistant commensals. The decreased risk associated with school 274 
attendance has been observed in a previous study in Spain[20], and may represent a proxy 275 
marker for increased socio-economic status, and parental levels of education, which were not 276 
evaluated here, but may translate into better awareness of appropriate antibiotic use[21, 22]. 277 
The decreased risk associated with male gender is unexplained; but independent associations 278 
for ESBL-EC/KP colonization have been described for both genders in previous studies[18, 279 
23, 24].   280 
 281 
Of particular importance was the high prevalence of chromosomal integration of blaCTX-M in 282 
E. coli in this study (>14%), perhaps contributing to the stable propagation of this resistance 283 
gene family within certain strains. Whilst the previously reported chromosomal integration of 284 
blaCTX-M in Spanish K. pneumoniae isolates was not observed in our study, this could not be 285 
excluded for three isolates in which the blaCTX-M genetic location (i.e. either plasmid or 286 
chromosomal) remained indeterminate due to the limitations of the genetic assemblies [25]. 287 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
In addition, despite the limitations of short-read assemblies, the genetic contexts of blaCTX-M 288 
suggested high levels of genetic plasticity in flanking structures, and significant associations 289 
with IS26 for blaCTX-M-15, blaCTX-M-55, and blaCTX-M-27. IS26 has been previously hypothesised 290 
to facilitate the mobility of blaCTX-M and genetic rearrangement of resistance gene plasmids, 291 
and is likely contributing to the dissemination of these resistance genes within the human 292 
gastrointestinal reservoir[26-28].  293 
 294 
This study has several limitations. Our survey dates from 2012, and the epidemiology of 295 
ESC-R EC/KP carriage may have changed in the intervening timeframe. We only included up 296 
to three bacterial colonies per faecal sample, likely resulting in significant under-estimation 297 
of the diversity present at the population level[14]. Also, storage conditions for faecal 298 
samples may have impacted on the isolates that were cultured. Short-read sequencing resulted 299 
in limited information regarding the wider genetic context of important resistance genes 300 
conferring ESC-R; nevertheless, we were still able to ascertain that the genetic contexts of 301 
these resistance genes are extremely diverse. Our outpatient study population may not be 302 
truly representative of healthy children in the community, given that these were individuals 303 
that had presented to the outpatient department for some form of medical review. Lack of 304 
more detailed information on some potential risk factors meant we were unable to fully assess 305 
the specific mechanisms promoting ESC-R EC/KP colonisation. Further work characterising 306 
the role of healthcare admissions, socio-economic factors and intestinal parasites on the 307 
acquisition and long-term carriage dynamics of these strains would be valuable. In addition, 308 
our sample size was too small and sparse to investigate geographical clustering of strain 309 
types, and to investigate specific risk factors for colonisation with common strain types or 310 
resistance gene alleles. Despite these limitations, our data are important as they represent the 311 
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largest molecular epidemiological study of gastrointestinal ESC-R-EC/KP colonisation in 312 
Cambodia and form a useful benchmark for future studies. 313 
 314 
CONCLUSION 315 
This study adds to the growing body of literature demonstrating widespread gastrointestinal 316 
colonisation with ESC-R-EC and ESC-R KP in Southeast Asia[8], and showing that exposure 317 
to this reservoir may in turn act as a source for the wider, global transfer of these strains[29]. 318 
The genetic contexts of important resistance genes are highly mosaic, consistent with rapid 319 
exchange of resistance genes within and between bacterial hosts. Significant levels of 320 
chromosomal integration of the most important ESC-R gene family, blaCTX-M, were also 321 
observed, and may result in these genes being stably maintained and propagated in one of the 322 
most common community-associated pathogens, namely E. coli. Our observations are 323 
alarming and, in the context of widespread, unregulated and often inappropriate antibiotic 324 
use, as seen in Cambodia, these selection pressures are likely to further facilitate the 325 
dissemination of AMR genes. 326 
 327 
METHODS 328 
Patients and setting 329 
Faecal samples were obtained from a consecutive subset of children/adolescents (<16 years) 330 
who had been enrolled in a prospective study that aimed to identify the prevalence of 331 
intestinal parasites in children/adolescents attending Angkor Hospital for Children in Siem 332 
Reap, Cambodia, from 3rd April 2012 to 29th June 2012, as described previously[30]. 333 
Informed consent was obtained by explaining the study to children/adolescents and their 334 
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caregivers, and confirmed by the caregiver’s signature or a witnessed thumbprint if they were 335 
illiterate. 336 
 337 
Microbiological methods 338 
Samples were frozen at -80°C as aliquots homogenised in 0.9% sterile saline with 10% 339 
glycerol within an hour of receipt in the laboratory. For this study, faecal samples were 340 
thawed, and aliquots diluted 1:10 in saline and incubated for 16 hours at 37°C on Orientation 341 
CHROMagar (BD, Oxford, United Kingdom) with 10 µg cefpodoxime and 10 µg imipenem 342 
discs (Oxoid, Basingstoke, United Kingdom). For each faecal sample, up to three pink and/or 343 
dark blue colonies with different colonial morphotypes that grew within the cefpodoxime 344 
zone of inhibition (presumed ESC-R-EC and ESC-R-KP respectively) were selected for 345 
further analysis. Each selected colony was tested using the British Society of Antimicrobial 346 
Chemotherapy (BSAC) combination disc method to identify whether cefpodoxime (ESC) 347 
resistance was mediated via ESBLs (Class A: cefpodoxime-resistant, and 348 
cefpodoxime+clavulanic acid-sensitive) or via non-ESBL mechanisms (e.g. Class C AmpC 349 
beta-lactamases: cefpodoxime-resistant, and cefpodoxime+clavulanic acid-resistant)[31]. All 350 
identified ESC-R colonies were stored frozen at -80°C in nutrient broth with 10% glycerol. 351 
Carbapenem susceptibility testing was performed via BD Phoenix automated susceptibility 352 
testing (microbroth dilution method; Becton Dickinson, Franklin Lakes, NJ, USA). 353 
 354 
Whole genome sequencing and sequence data processing 355 
DNA was extracted from sub-cultured ESC-R isolates using a commercial kit (Fujifilm 356 
Quickgene, Japan) with an additional mechanical lysis step (Fastprep MP Biomedicals, 357 
USA). All isolates were sequenced using the Illumina HiSeq 2500, generating 150bp paired-358 
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end reads. Sequence data have been deposited in GenBank (project accession: 359 
PRJNA391054). 360 
 361 
To identify single nucleotide variants (SNVs) reads were mapped to species-appropriate 362 
reference genomes (E. coli CFT073 [GenBank: AE014075.1] and K. pneumoniae 363 
MGH78578 [GenBank: CP000647.1]), and variants called as described previously[32]. 364 
Alignments of variable sites were padded to the length of the reference genome using bases 365 
with the same %GC content as that observed within each dataset. Bootstrapped, maximum-366 
likelihood phylogenies were reconstructed for each species using RaxML version 7.7.6[33], 367 
using a generalised time-reversible model and four categories of rate heterogeneity 368 
(./RAxML-7.7.6/raxmlHPC-PTHREADS-SSE3 -f a -s <input_alignment.phy> -m 369 
GTRGAMMA -p 12345 -c 4 -x 12345 -# 100 -n <output_raxml_rapid_bootstrap>). 370 
Phylogenies have been deposited as projects in MicroReact to enable an interactive 371 
assessment of geographic distribution of genotypes (E. coli: 372 
https://microreact.org/project/By8bf5ajg; K. pneumoniae: 373 
https://microreact.org/project/Hy_yQcaog[34].  374 
 375 
Contigs were assembled using Velvet/VelvetOptimiser (hash value range: 75-149)[35, 36]. In 376 
silico MLST was determined by BLASTn[37] matches (100% match) to the Achtman/Pasteur 377 
MLST schemes for E. coli and K. pneumoniae[38, 39], and supported correct species 378 
identification. The presence/absence of resistance genes was determined using BLASTn and 379 
an in-house curated resistance gene database of over 60 gene families[40]. Genes were 380 
considered present if a blast match of ≥80% of the query sequence was identified at ≥80% 381 
sequence identity using the de novo assemblies as blast databases.  Ambler class genotype 382 
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was class A if blaCTX-M, blaSHV and/or blaVEB were present, and/or class C if blaCMY-2, blaDHA 383 
and blaACT-like genes were present. Where patient faecal samples yielded ≥2 strains, all 384 
resistance genes were treated as a single entity within the individual’s profile. 385 
 386 
The genetic context of blaCTX-M was examined by extracting the contigs containing these 387 
genes, and annotating these using PROKKA[41], combined with BLASTn and manual 388 
annotation with reference to mobile genetic elements in the ISFinder database[42]. Gene 389 
locations were characterised as “chromosomal” if other annotations on the contig were only 390 
found in chromosomal contexts in the top 20 BLASTn hits when the contig was compared 391 
with bacterial sequences available in GenBank (using default parameters); “plasmid” if the 392 
other annotations matched only plasmid sequences; or unknown if these conditions were not 393 
met e.g. the assembled contigs were too short to verify this.   394 
 395 
Epidemiological analyses 396 
Information regarding putative socio-demographic risk factors for ESC-R EC/KP 397 
colonisation (collected on a standardised form) included details on: gender, age, 398 
hospitalisation status, residence in Siem Reap province versus elsewhere, water source (river, 399 
rain, well, bottled, piped, boiled), domestic animals (cats, dogs, birds), livestock (chickens, 400 
ducks, pigs, cows or water buffalo), toilet availability, malnutrition, co-morbidities, 401 
presence/absence of diarrhoea, presence/absence of parasites (assessed within [30]), soap 402 
usage for hand-washing and school attendance. No details regarding antibiotic consumption 403 
were ascertained within the study, but previous work locally has shown that individuals are 404 
often ill-informed about the nature of any medications used and that 32% of outpatient 405 
attendees have evidence of urinary antimicrobial activity[43]. 406 
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 407 
Statistical analyses 408 
Independent risk factors for carriage were identified from a multivariable, stepwise, logistic 409 
regression model based on complete cases and initially including all factors (backwards 410 
elimination using exit p<0.1 to reduce over-fitting). A final multivariable logistic model was 411 
then fitted including all cases for which complete information was available for the retained 412 
risk factors. Statistical analyses were performed using STATA version 14 (StataCorp, 413 
College Station, USA).   414 
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FIGURE LEGENDS 461 
Figure 1. 462 
Phylogeny of study Escherichia coli isolates. Interactive map of geographic locations and 463 
genetic attributes can be visualised at: https://microreact.org/project/By8bf5ajg 464 
 465 
Figure 2. 466 
Phylogeny of study Klebsiella pneumoniae isolates. Interactive map of geographic locations 467 
and genetic attributes can be visualised at: https://microreact.org/project/Hy_yQcaog 468 
 469 
Figure 3. Schematic of aligned genetic contexts for blaCTX-M-15 in study Escherichia coli. 470 
Features of interest are highlighted in the figure key. White numbers within open reading 471 
frames denote truncated sequence length (bp). Isolates harbouring this genetic context are 472 
listed to the left of the figure. “x” denotes contig breaks. P denotes plasmid contexts; c 473 
chromosomal contexts. 474 
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Figure 4.  Schematic of aligned genetic contexts for blaCTX-M-55 in study Escherichia coli. 476 
Features of interest are highlighted in the figure key. White numbers within open reading 477 
frames denote truncated sequence length (bp). Isolates harbouring this genetic context are 478 
listed to the left of the figure. “x” denotes contig breaks. P denotes plasmid contexts; c 479 
chromosomal contexts. 480 
 481 
Figure 5. Schematic of aligned genetic contexts for blaCTX-M-14 in study Escherichia coli and 482 
Klebsiella pneumoniae. Features of interest are highlighted in the figure key. White numbers 483 
within open reading frames denote truncated sequence length (bp). Isolates harbouring this 484 
genetic context are listed to the left of the figure. “x” denotes contig breaks. P denotes 485 
plasmid contexts; c chromosomal contexts.486 
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TABLES 487 
Table 1. Clinical and epidemiological details of all 148 participants, also categorised by presence/absence of gastrointestinal colonisation 488 
with ESC-resistant E. coli and/or K. pneumoniae, and multivariable logistic regression outcomes 489 
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 Overall  
(n=148) 
ESC-R E. coli/ 
K. pneumoniae 
colonised 
(n=82; 55%) 
ESC-R E. coli/ 
K. pneumoniae 
non-colonised 
(n=66; 45%) 
Univariable logistic 
regression for ESC-R 
carriage 
Multivariable logistic 
regression for ESC-R 
carriage¥ 
 Number (%) 
unless otherwise 
specified 
n (%) n (%) OR [95% CI] p OR [95% CI] p 
Median age [IQR], years 4.24 [1.10 - 8.82] 3.07 [0.97 - 7.21] 6.23 [1.32 - 9.23] 1.00 [1.00-1.00] 0.712   
Male 70 (47) 35 (43) 35 (53) 0.66 [0.34-1.27] 0.211 0.39 [0.18-0.84] 0.015 
Inpatient* 70 (48) 49 (60) 20 (32) 3.28 [1.66-6.50] 0.001 3.64 [1.71-7.74] 0.001 
Province        
Siem Reap  99 (67) 51 (62) 48 (72) 1    
Other (versus Siem 
Reap)¶ 
49 (33) 31 (38) 18 (28) 1.06 [0.72-1.58] 0.716   
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Malnutrition 16 (11) 12 (15) 4 (6) 2.66 [0.81-8.67] 0.105   
Co-morbidities§ 25 (17) 19 (23) 6 (9) 3.01 [1.13-8.06] 0.028   
Diarrhoea present& 70 (48) 44 (54) 26 (40) 1.78 [0.92-3.46] 0.086   
Water sources        
Well 123 (83) 64 (78) 59 (89) 0.42 [0.16-1.08] 0.073   
Bottled 17 (11) 13 (16) 4 (6) 2.92 [0.90-9.43] 0.073   
River 5 (3) 3 (4) 2 (3) 1.22 [0.20-7.49] 0.834   
Rain 8 (5) 5 (6) 3 (5) 1.36 [0.31-5.93] 0.680   
School attendance 71 (48) 32 (39) 39 (59) 0.44 [0.23-0.86] 0.016 0.39 [0.18-0.83] 0.015 
All animals 119 (80) 65 (79) 54 (82)     
Domestic animals 113 (76) 61 (74) 50 (79) 0.78 [0.36-1.69] 0.532   
Cat 51 (34) 32 (39) 19 (29) 1.58 [0.79-3.17] 0.194   
Dog 100 (68) 57 (70) 43 (65) 1.22 [0.61-2.43] 0.573   
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Birds 24 (16) 12 (15) 12 (18) 0.77 [0.32-1.85] 0.561   
Livestock/food 
animals  
89 (60)  54 (66) 35 (53) 1.71 [0.88-3.32 0.114   
Water 
buffalo 
4 (3) 3 (4) 1 (1) 2.47 [0.25-24.3] 0.439   
Chickens 80 (54) 49 (60) 31 (47) 1.67 [0.87-3.23] 0.122   
Pigs 23 (16) 14 (17) 9 (14) 1.30 [0.53-3.23] 0.567   
Ducks 2 (1) 2 (2) 0 1 (omitted)    
Cattle 24 (16) 15 (18) 9 (14)  1.42 [0.58-3.48] 0.446   
Use of toilet for 
defecation 
88 (59) 45 (54)  42 (65) 0.65 [0.33-1.27] 0.207   
Use of soap#        
Never 34 (23) 18 (23) 16 (25) 1    
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Some use (versus 
Never) 
111 (77) 62 (76) 49 (75) 1.12 [0.52-2.43] 0.765   
Presence of intestinal 
parasites 
36 (24) 25 (30.49) 11 (17.19) 2.19 [0.99-4.88] 0.054 3.96 [1.55-10.12] 0.004 
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 * missing one datapoint (n=147)  
& missing two datapoints (n=146) 
# missing three datapoints (n=145) 
¥ Backwards elimination performed using 144 cases for which complete information available, on all predictors, using exit p≤0.1. 
Final model then incorporated 147 cases for which complete information available on included predictors (gender, inpatient status, 
presence of intestinal parasites and school attendance)  
¶ “Other province” category includes: Banteay Meanchey (n=21), Oddar Meanchey (8), Kampong Thom (6), Battambang (5), Preah 
Vihear (3), Kampong Cham (2), Kampong Chhang (1), Pursat (1), Other (2)  
§ Includes: HIV (n=5), blood dyscrasia (3), Down’s syndrome (2), congenital heart disease (6), tuberculosis (4), asthma (2), other 
(8); five individuals had multiple co-morbidities 
p-values <0.05 in bold  
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Table 2. Summary of Ambler Class A and C phenotypes and genotypes in ESC-resistant E. coli and K. pneumoniae isolates 491 
  Amber Class Phenotype   
 E. coli (n = 97) K. pneumoniae (n = 17) Both species (n = 114) Total 
 A (n = 74) C (n = 23) A (n = 14) C (n = 3) A (n = 88) C (n = 26) (n = 114) 
Ambler Class A genes      
blaCTX-M positive 
†  73 (99%) 18 (78%) 14 (100%) 2 (67%) 87 (99%) 20 (77%) 107 (94%) 
     CTX-M-14     14     1     2     0     16     1     17  
     CTX-M-15     28     13      12     0     40     13     53 
     CTX-M-24     2      1     0     0     2     1     3 
     CTX-M-27     12     0     0     2      12     2     14 
     CTX-M-55     20     4     0     0     20     4     24 
     Total           76     19     14     2     90     21     111 
blaSHV positive 0 (0%) 0 (0%) 12 (86%) 2 (67%) 12 (14%) 2 (8%) 14 (12%) 
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38 
39 
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41 
42 
43 
44 
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58 
59 
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61 
62 
63 
64 
65 
     SHV-1/1-like**     0     0     2     1      2      1     3 
     SHV-11/11-like**     0     0     2     1      2     1     3 
     SHV-27*     0     0     1     0     1     0     1 
     SHV-28*     0     0     1     0     1     0     1 
     SHV-33**     0     0     3     0     3     0     3 
     SHV-83**     0     0     1     0     1     0     1 
     SHV-99/99-like*     0     0     1     0     1     0     1 
     SHV-142¥     0     0     1     0     1      0     1 
     Total     0     0     12     2     12      2    14 
blaVEB positive 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 0 (0%) 1 (1%) 
None identified 0 5 (22%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 5 (4%) 
Ambler Class C genes      
blaCMY-2 positive 0 (0%) 8 (35%) 0 (0%) 0 (0%) 0 (0%) 8 (31%) 8 (31%) 
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blaDHA positive 0 (0%) 1 (4%) 0 (0%) 1 (33%) 0 (0%) 2 (8%) 2 (8%) 
blaACT-like positive 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
None identified 0 (0%) 14 (61%) 0 (0%) 2 (67%) 0 (0%) 16 (62%) 16 (62%) 
† Isolates with two separate blaCTX-M alleles were identified in 4% of isolates (4/114) 492 
* ESBL 493 
** not ESBL 494 
¥ Unknown beta-lactamase phenotype 495 
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Table 3. Summary of genetic contexts of blaCTX-M in ESC-resistant E. coli and K. pneumoniae  497 
 blaCTX-M-15 blaCTX-M-55 blaCTX-M-14 blaCTX-M-27 blaCTX-M-24 
 EC 
(n=41) 
KP 
(n=12) 
EC 
(n=24) 
KP 
(n=0) 
EC 
(n=15) 
KP 
(n=2) 
EC 
(n=12) 
KP 
(n=2) 
EC 
(n=3) 
KP 
(n=0) 
Location (chromosome versus plasmid) 
Chromosomal 5 (12%) 0 4 (17%) - 2 (13%) 0 0 0 2 (67%) - 
Likely plasmid 2 (5%) 9 (75%) 4 (17%) - 5 (33%) 2 (100%) 0 0 1 (33%) - 
Not determined 34 (83%) 3 (25%) 16 (67%) - 8 (53%) 0 12 (100%) 2 (100%) 0 - 
Evaluable 
immediate 
flanking context 
n=40* n=12 n=23¥ - n=15 n=2 n=12 n=2 n=3 - 
ISEcp1 upstream 40 (100%) 12 (100%) 23 (100%) - 15 (100%) 2 (100%) 12 (100%) 2 3 (100%) - 
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24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3’ GACTA target 
site sequence 
(TSS) at 48bp 
upstream of 
blaCTX-M 
36 (90%) 12 (100%) 23 (100%) - 0 0 0 0 0 
 
- 
3’ TTTCA TSS at 
127bp upstream of 
blaCTX-M 
4 (10%) 0 0 - 0 0 0 0 0 - 
3’ GAATA TSS at 
42bp 
0 0 0 - 15 (100%) 2 (100%) 12 (100%) 2 (100%) 3 (100%) - 
ISEcp1 
incomplete 
26 (65%) 0 14 (61%) - 6 (40%) 0 12 (100%) 2 (100%) 1 (100%) - 
due to IS26 
element 
13** (32%) 
L IRR - 11 
0 12† (52%) 
L IRR - 1 
- 0 0 12 (100%) 
L IRR - 12 
2 (100%) 
L IRR - 2 
0 - 
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21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
R IRR - 2 R IRR - 11 
due to contig break 13 (32%) 0 2 (9%) - 3 (20%) 0 0 0 1 (33%) - 
due to ISVsa5-like 0 0 0 - 2 (13%) 0 0 0 0 - 
due IS1S R IRR 0 0 0 - 1 (7%) 0 0 0 0 - 
ISEcp1 complete 13 (32%) 12 (100%) 9 (39%) - 9†† (60%) 2 (100%) 0 0 2 (67%) - 
5’ TCATA TSS 9 (22%) 12 (100%) 4 (17%) - 0 0 0 0 0 - 
5’ TAATA TSS 4 (10%) 0 3 (13%) - 0 0 0 0 0 - 
5’ TAACA TSS 
5’ CATTA TSS 
5’ AAATA TSS 
5’ TAAAA TSS 
5’ GCCGA TSS 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 (14%) 
0 
0 
0 
0 
- 
- 
- 
- 
- 
0 
4 (44%) 
2 (22%) 
1 (11%) 
1 (11%) 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 (33%) 
0 
0 
0 
- 
- 
- 
- 
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5’ TATAT TSS 
5’ TAGCA TSS 
0 
0 
0 
0 
0 
0 
- 
- 
0 
0 
0 
2 (100%) 
0 
0 
0 
0 
1 (33%) 
0 
- 
- 
EC = E. coli, KP = K. pneumoniae 498 
* excluding one isolate with short contigs harbouring truncated blaCTX-M-15  499 
** ISEcp1 truncated at 24, 497, 524, 1067, 1173, 1421, or 1489bp. 500 
¥ excluding one isolate with short contig harbouring truncated blaCTX-M-55 501 
† ISEcp1 truncated at 267, 309 or 497bp 502 
†† For one only 1 bp of 5’ TSS evaluable 503 
¶ ISEcp1 truncated at 149, 192, 208 and 388bp 504 
TSS=target site sequence 505 
L IRR=left inverted repeat region 506 
R IRR=left inverted repeat region 507 
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ADDITIONAL FILES 660 
 661 
Additional File 1:  662 
- File: bmcmicro_camb_esbl_figS1_23122017.pdf 663 
- Title: Figure S1 664 
- Description: Schematic of aligned genetic contexts for blaCTX-M-24 in study Escherichia coli. 665 
Features of interest are highlighted in the figure key. White numbers within open reading 666 
frames denote truncated sequence length (bp). Isolates harbouring this genetic context are 667 
listed to the left of the figure. “x” denotes contig breaks. P denotes plasmid contexts; c 668 
chromosomal contexts. 669 
 670 
Additional File 2:  671 
- File: bmcmicro_camb_esbl_figS2_23122017.pdf 672 
- Title: Figure S2 673 
- Description: Schematic of aligned genetic contexts for blaCTX-M-27 in study Escherichia coli 674 
and Klebsiella pneumoniae. Features of interest are highlighted in the figure key. White 675 
numbers within open reading frames denote truncated sequence length (bp). Isolates 676 
harbouring this genetic context are listed to the left of the figure. “x” denotes contig breaks. P 677 
denotes plasmid contexts; c chromosomal contexts. 678 
 679 
Additional File 3: 680 
- Figure: bmcmicro_camb_esbl_figS3_23122017.pdf 681 
- Title: Figure S3 682 
- Description: Schematic of aligned genetic contexts for blaCTX-M-15 in study Klebsiella 683 
pneumoniae. Features of interest are highlighted in the figure key. White numbers within 684 
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open reading frames denote truncated sequence length (bp). Isolates harbouring this genetic 685 
context are listed to the left of the figure. “x” denotes contig breaks. P denotes plasmid 686 
contexts; c chromosomal contexts. 687 
 688 
Additional File 4: 689 
- File: bmcmicro_camb_esbl_supplementary_info_17022019.docx 690 
- Title: Supplementary Tables 691 
- Description: Table S1. Sequence type distribution of E. coli isolates obtained in this study. 692 
Table S2. Sequence type distribution of K. pneumoniae isolates obtained in this study 693 
 694 
Additional File 5: 695 
- File: bmcmicro_camb_esbl_tableS3_23122017.xlsx 696 
- Title: Table S3 697 
- Description: Detail of genetic contexts for blaCTX-M in sequenced isolates. 698 
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